For the vaccination of healthy horses as an aid in the prevention of equine viremia due to West Nile Virus. Read More
This item cannot ship to Canada
Cannot ship to P.O. Box
Recombitek® West Nile Virus vaccine contains a lyophilized recombinant canarypox vector, modified using recombinant technology, to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation, the vector does not multiply in the horse, but does express the protective proteins. As a consequence, these components induce an immune response against West Nile Virus.
For the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus.
Give 1 mL IM, repeat in 4 to 6 weeks. Revaccinate annually with a single dose. Live canarypox vector, requires mixing.
Syringes and needles are NOT included.